scholarly article | Q13442814 |
P50 | author | Nivedita Borkakoti | Q84337992 |
James M Bennett | Q103837496 | ||
P2093 | author name string | Ian Kilford | |
Trevor Wilkinson | |||
David Hurst | |||
Philip S. Jones | |||
Stephen D. Pickett | |||
Michael Broadhurst | |||
Murray McKinnell | |||
Bradley S. Sherborne | |||
P2860 | cites work | Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group | Q27861083 |
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group | Q29620719 | ||
Detailed analysis of scoring functions for virtual screening | Q30985789 | ||
Molecular complexity and its impact on the probability of finding leads for drug discovery | Q30993107 | ||
Is there a difference between leads and drugs? A historical perspective | Q31017131 | ||
The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors | Q31401240 | ||
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening | Q31406783 | ||
Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors | Q31572098 | ||
The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure | Q34326042 | ||
Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming | Q34447822 | ||
Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. | Q40874319 | ||
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. | Q46186465 | ||
Docking of hydrophobic ligands with interaction-based matching algorithms. | Q51646570 | ||
Multiple automatic base selection: protein-ligand docking based on incremental construction without manual intervention. | Q52260133 | ||
A fast flexible docking method using an incremental construction algorithm. | Q52298930 | ||
MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. | Q52340891 | ||
A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1 | Q57704207 | ||
Discovering high-affinity ligands for proteins | Q73904870 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
organic chemistry | Q11351 | ||
molecular medicine | Q3523816 | ||
pharmaceutical science | Q7180763 | ||
P1104 | number of pages | 4 | |
P304 | page(s) | 1691-1694 | |
P577 | publication date | 2003-05-01 | |
2003-05-19 | |||
P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
P1476 | title | Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening | |
P478 | volume | 13 |
Q33225368 | Design of ligand binding to an engineered protein cavity using virtual screening and thermal up-shift evaluation. |
Q27660547 | Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition |
Q30366496 | Virtual screening: an in silico tool for interlacing the chemical universe with the proteome. |
Search more.